Gyre Therapeutics (GYRE) FCF Margin Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 10,029.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 723.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,409.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,066.00 |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | -2,138.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,138.00 |
| Dec 31, 2025 | -5,712.00 |
| Mar 31, 2025 | 151,649.00 |
| Dec 31, 2024 | 71,476.00 |
| Sep 30, 2024 | 96,499.00 |
| Jun 30, 2024 | 175,010.00 |
| Mar 31, 2024 | 167,002.00 |
| Dec 31, 2023 | 109,264.00 |
| Sep 30, 2023 | 149,600.00 |
| Jun 30, 2023 | 92,088.00 |
| Mar 31, 2023 | 6,417.00 |
| Mar 31, 2021 | 8.68 Mn |
| Dec 31, 2020 | 90,394.00 |
| Sep 30, 2020 | 7,150.00 |
| Jun 30, 2020 | 305,189.00 |
| Mar 31, 2020 | 155,550.00 |
| Mar 31, 2018 | -8.80 Mn |
| Dec 31, 2017 | -168,637.00 |
| Sep 30, 2017 | -510,192.00 |
| Jun 30, 2017 | -96,476.00 |
| Mar 31, 2017 | 341,378.00 |
| Dec 31, 2016 | -3.22 Mn |
| Mar 31, 2016 | -416,839.00 |
| Dec 31, 2015 | -280,802.00 |
| Sep 30, 2015 | -747,926.00 |
| Jun 30, 2015 | -10,734.00 |
| Mar 31, 2015 | -33,431.00 |
| Dec 31, 2014 | -19,671.00 |
| Sep 30, 2014 | 364,819.00 |
| Jun 30, 2014 | -288,783.00 |
| Mar 31, 2014 | -494,059.00 |
| Dec 31, 2013 | 2.50 Mn |